In another study, the therapeutic potential of fisetin for treating depression was found to be mediated via activation of TrkB signaling pathway and leads to increase in phosphorylation of TrkB level without disturbing total TrkB [85]. This evidence concerns the gene NTRK2 and major depressive disorder.